Tumor type | Incidence of bone metastases (%) | |||
---|---|---|---|---|
1-year (95% CI) | 2-year (95% CI) | 5-year (95% CI) | 10-year (95% CI) | |
All tumor types combined (N = 382,733) | 4.8 (4.7–4.8) | 5.6 (5.5–5.6) | 6.9 (6.8–7.0) | 8.4 (8.3–8.5) |
Breast (N = 137,720) | 3.4 (3.3–3.5) | 4.2 (4.1–4.3) | 6.0 (5.8–6.1) | 8.1 (7.9–8.3) |
Prostate (N = 22,801) | 18.0 (17.5–18.5) | 20.4 (19.9–20.9) | 24.5 (23.9–25.1) | 29.2 (28.3–30.1) |
Lung (N = 59,344) | 10.4 (10.2–10.7) | 11.5 (11.3–11.8) | 12.4 (12.1–12.7) | 12.9 (12.6–13.2) |
Colorectal (N = 46,832) | 1.0 (0.9–1.1) | 1.4 (1.3–1.5) | 2.1 (2.0–2.3) | 2.7 (2.5–2.9) |
Gastrointestinal (N = 32,874) | 2.3 (2.1–2.5) | 2.7 (2.6–2.9) | 3.2 (3.0–3.4) | 3.6 (3.3–3.8) |
Gynecological (N = 21,075) | 1.1 (0.9–1.2) | 1.3 (1.2–1.5) | 1.9 (1.7–2.1) | 2.4 (2.1–2.7) |
Malignant melanoma (N = 12,152) | 1.6 (1.4–1.8) | 2.0 (1.7–2.2) | 2.5 (2.2–2.8) | 3.0 (2.6–3.4) |
Renal (N = 17,717) | 5.8 (5.5–6.2) | 6.9 (6.6–7.3) | 8.4 (8.0–8.9) | 9.9 (9.3–10.5) |
All other tumors (N = 32,218) | 2.0 (1.8–2.1) | 2.5 (2.3–2.7) | 3.2 (3.0–3.4) | 3.9 (3.5–4.2) |